Announcements Trials

Browse Landscape

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 5 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Biliary Tract Neoplasms 3 Nevi and Melanomas 2 Neoplastic Cells, Circulating 2 Neoplasm, Residual 2 Melanoma 2 Lung Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Recurrence 1 Prostatic Neoplasms 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neurofibrosarcoma 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neoplasms 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Gastrointestinal Stromal Tumors 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Lobular 1

Interventions

Blood Specimen Collection 38 pembrolizumab 36 Bevacizumab 22 Surveys and Questionnaires 18 Standard of Care 18 Radiotherapy 18 Exercise 17 Carboplatin 16 Nivolumab 15 atezolizumab 14 Cisplatin 14 Drug Therapy 13 Paclitaxel 12 Fluorouracil 12 Cyclophosphamide 12 Cetuximab 12 Trastuzumab 10 Leucovorin 10 Docetaxel 10 Dexamethasone 10 Pemetrexed 9 Oxaliplatin 9 Biopsy 9 pertuzumab 8 olaparib 8 Temozolomide 8 Panitumumab 8 Observation 8 Irinotecan 8 abemaciclib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Liquid Biopsy × Clear all

NCT05504772 2024-07-17

ZERO2

Australian & New Zealand Children's Haematology/Oncology Group

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡